id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-B-0228-0003,FDA,FDA-2001-B-0228,Guidance,Supporting & Related Material,GDL-Guidance,2003-11-13T05:00:00Z,2003,11,,,2008-04-25T02:37:02Z,,0,0,09000064804e59f9
FDA-2001-B-0228-0004,FDA,FDA-2001-B-0228,FDA,Notice,NAD-Notice of Availability of Data,2003-11-13T05:00:00Z,2003,11,2003-11-12T05:00:00Z,,2008-04-25T02:37:02Z,,0,0,09000064804e59fc
FDA-2001-B-0228-0002,FDA,FDA-2001-B-0228,Guidance,Supporting & Related Material,GDL-Guidance,2003-11-13T05:00:00Z,2003,11,,,2008-04-25T02:37:02Z,,0,0,09000064804e59e7
FDA-2001-B-0228-0001,FDA,FDA-2001-B-0228,FDA,Notice,N-Notice,2002-02-13T05:00:00Z,2002,2,2002-02-13T05:00:00Z,2002-03-15T04:59:59Z,2008-04-25T02:37:02Z,,0,0,09000064804e59a8